The potential beneficial role of faecal microbiota transplantation in diseases other than Clostridium difficile infection R. Singh, M. Nieuwdorp, I.J.M.

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-C. Lagier Clinical Microbiology and Infection

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

Changes in the intestinal microbiota from adulthood through to old age

Herpes zoster in non-hospitalized children

European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Data review and recommendations for diagnosing Clostridium difficile-infection.

Migrant health—a cause for concern?

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Faecal microbiota transplantation—the Austrian approach

J.-P. Van geertruyden Clinical Microbiology and Infection

Hepatitis B and C virus-related carcinogenesis

Infectious causes of cancer: an evolving educational saga

R. Cantón Clinical Microbiology and Infection

P. Nordmann, L. Poirel Clinical Microbiology and Infection

New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to.

Link between intracellular pathogens and cardiovascular diseases

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Surveillance of Legionnaires’ disease in Austria

Impact of antibiotic restrictions: the pharmaceutical perspective

Vector control: a cornerstone in the malaria elimination campaign

Training for the infectious diseases speciality in Norway

Laboratory diagnosis and biosafety issues of biological warfare agents

CMI editorial report 2011 Clinical Microbiology and Infection

Hepatitis C virus and interferon type III (interferon-λ3/interleukin-28B and interferon-λ4): genetic basis of susceptibility to infection and response.

Elements of design: the knowledge on which we build

The role of tigecycline in the management of Clostridium difficile infection: a retrospective cohort study E. Manea, J. Sojo-Dorado, R.E. Jipa, S.N.

Levofloxacin in the treatment of ventilator-associated pneumonia

G. Pappas Clinical Microbiology and Infection

Mathematical modeling of Clostridium difficile infection

Metagenomics and probiotics

Hepatitis B and C virus-related carcinogenesis

Laboratory diagnosis of Clostridium difficile disease

The practice of travel medicine in Europe

Antibacterial drug discovery in the 21st century

The role of antimalarial treatment in the elimination of malaria

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Antimicrobial drug development – the past, the present, and the future

V. Spoorenberg, J. M. Prins, B. C. Opmeer, T. M. de Reijke, M. E. J. L

R. U. Varier, E. Biltaji, K. J. Smith, M. S. Roberts, M. K. Jensen, J

An after-hours clinical liaison blood culture service—is it worth it?

Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013 U. Fedeli, E. Schievano,

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Clinical Microbiology and Infection

Microbiologic factors affecting Clostridium difficile recurrence

Changing pattern of candidaemia 2001–2006 and use of antifungal therapy at the University Hospital of Vienna, Austria E. Presterl, F. Daxböck, W. Graninger,

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

C.P. Kelly Clinical Microbiology and Infection

F.J. Pastor, J. Guarro Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

C. Novais, T.M. Coque, J.C. Sousa, L.V. Peixe

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

Modelling during an emergency: the 2009 H1N1 influenza pandemic

First implementation of frozen, capsulized faecal microbiota transplantation for recurrent Clostridium difficile infection into clinical practice in Europe

Are we losing the fight against malaria one more time?

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Three years experience of real-time PCR for the diagnosis of Q fever

Typing of Clostridium difficile

Impact of antibiotic restrictions: the patient's perspective

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

The potential beneficial role of faecal microbiota transplantation in diseases other than Clostridium difficile infection R. Singh, M. Nieuwdorp, I.J.M. ten Berge, F.J. Bemelman, S.E. Geerlings Clinical Microbiology and Infection Volume 20, Issue 11, Pages 1119-1125 (November 2014) DOI: 10.1111/1469-0691.12799 Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Alterations within the gut microbiota under healthy conditions and in inflammatory bowel disease (IBD). IL-8, interleukin-8; NF-κB, nuclear factor-κB. Clinical Microbiology and Infection 2014 20, 1119-1125DOI: (10.1111/1469-0691.12799) Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions